# Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis

> **NCT00221546** · PHASE2 · COMPLETED · sponsor: **University Hospital, Ghent** · enrollment: 17 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Giving DHA-rich supplement

## Key facts

- **NCT ID:** NCT00221546
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2011-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00221546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00221546, "Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00221546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*